China Pharmaceutical Contract Manufacturing Services Market, 2020-2030
Roots Analysis is pleased to announce the publication of its recent study, titled, "China Pharmaceutical Contract Manufacturing Services Market, 2020-2030."
By: Roots Analysis
The report features an extensive study of the current market landscape and future opportunities associated with the pharmaceutical contract manufacturing market in China. The study also features a detailed analysis, highlighting the capabilities of pharmaceutical CMOs in this region. Amongst other elements, the report features:
§ A detailed assessment of the current market landscape of pharmaceutical contract manufacturers in China engaged in the development of active pharmaceutical ingredients (APIs), intermediates and finished dosage formulations (FDFs).
§ A detailed landscape of the pharmaceutical manufacturing facilities in China, including an analysis based on location of these facilities, highlighting key manufacturing hubs.
§ A brief discussion of various regulatory guidelines in China and various challenges, related to regulatory scrutiny, faced by pharmaceutical manufacturers in China.
§ Detailed profiles of key players that offer a diverse range of capabilities for the manufacturing of pharmaceutical products in China.
For more information please click on the following link:
Other Recent Offerings
1. China Biopharmaceutical Contract Manufacturing Market, 2020 – 2030
2. HPAPI and Cytotoxic Drugs Manufacturing Market (3rd Edition), 2020-2030
3. Novel coronavirus (COVID-19): Preventive Vaccines, Therapeutics and Diagnostics in Development
Roots Analysis Private Limited
+1 (415) 800 3415